These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6788699)

  • 1. Effect of monoclonal antibodies on phagocytosis and killing of Toxoplasma gondii by normal macrophages.
    Hauser WE; Remington JS
    Infect Immun; 1981 May; 32(2):637-40. PubMed ID: 6788699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal rat antibodies directed against Toxoplasma gondii suitable for studying tachyzoite-bradyzoite interconversion in vivo.
    Gross U; Bormuth H; Gaissmaier C; Dittrich C; Krenn V; Bohne W; Ferguson DJ
    Clin Diagn Lab Immunol; 1995 Sep; 2(5):542-8. PubMed ID: 8548532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatidylserine exposure by Toxoplasma gondii is fundamental to balance the immune response granting survival of the parasite and of the host.
    Santos TA; Portes Jde A; Damasceno-Sá JC; Caldas LA; Souza Wd; Damatta RA; Seabra SH
    PLoS One; 2011; 6(11):e27867. PubMed ID: 22140476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies against nucleoside triphosphate hydrolase-II can reduce the replication of Toxoplasma gondii.
    Tan F; Hu X; Pan CW; Ding JQ; Chen XG
    Parasitol Int; 2010 Jun; 59(2):141-6. PubMed ID: 20056166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granule-dependent killing of Toxoplasma gondii by CD8+ T cells.
    Nakano Y; Hisaeda H; Sakai T; Zhang M; Maekawa Y; Zhang T; Nishitani M; Ishikawa H; Himeno K
    Immunology; 2001 Nov; 104(3):289-98. PubMed ID: 11722643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous and intestinal vaccination with tachyzoites of Toxoplasma gondii and acquisition of immunity to peroral and congenital toxoplasma challenge.
    McLeod R; Frenkel JK; Estes RG; Mack DG; Eisenhauer PB; Gibori G
    J Immunol; 1988 Mar; 140(5):1632-7. PubMed ID: 3346545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific antibody-dependent killing of Toxoplasma gondii by normal macrophages.
    Anderson SE; Bautista SC; Remington JS
    Clin Exp Immunol; 1976 Dec; 26(3):375-80. PubMed ID: 1009680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii.
    Suzuki Y; Orellana MA; Schreiber RD; Remington JS
    Science; 1988 Apr; 240(4851):516-8. PubMed ID: 3128869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The zebrafish as a novel model for the
    Yoshida N; Domart MC; Peddie CJ; Yakimovich A; Mazon-Moya MJ; Hawkins TA; Collinson L; Mercer J; Frickel EM; Mostowy S
    Dis Model Mech; 2020 Jul; 13(7):. PubMed ID: 32461265
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of stage-specific sporozoite antigens of Toxoplasma gondii by monoclonal antibodies.
    Kasper LH; Bradley MS; Pfefferkorn ER
    J Immunol; 1984 Jan; 132(1):443-9. PubMed ID: 6197455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of alveolar macrophages on Toxoplasma gondii.
    Ryning FW; Remington JS
    Infect Immun; 1977 Dec; 18(3):746-53. PubMed ID: 591065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of monoclonal antibodies to detect antigens of Toxoplasma gondii in serum and other body fluids.
    Araujo FG; Handman E; Remington JS
    Infect Immun; 1980 Oct; 30(1):12-6. PubMed ID: 7439969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of neonatal spleen cell products on the multiplication of toxoplasma in rat peritoneal macrophages.
    Sakurai H; Igarashi I; Omata Y; Saito A; Suzuki N
    J Immunol; 1983 Sep; 131(3):1527-30. PubMed ID: 6886423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies to Toxoplasma cell membrane surface antigens protect mice from toxoplasmosis.
    Johnson AM; McDonald PJ; Neoh SH
    J Protozool; 1983 May; 30(2):351-6. PubMed ID: 6631778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice.
    Suzuki Y; Conley FK; Remington JS
    J Immunol; 1989 Sep; 143(6):2045-50. PubMed ID: 2506275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Infection of the athymic rat by Toxoplasma gondii].
    Santoro F; Auriault C; Leite P; Darcy F; Capron A
    C R Acad Sci III; 1987; 304(11):297-300. PubMed ID: 3103874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of muramyl dipeptide treatment on resistance to infection with Toxoplasma gondii in mice.
    Krahenbuhl JL; Sharma SD; Ferraresi RW; Remington JS
    Infect Immun; 1981 Feb; 31(2):716-22. PubMed ID: 7216470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation between mouse-virulent and -avirulent strains of Toxoplasma gondii by a monoclonal antibody recognizing a 27-kilodalton antigen.
    Bohne W; Gross U; Heesemann J
    J Clin Microbiol; 1993 Jun; 31(6):1641-3. PubMed ID: 8315008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural IgM antibodies in sera from various animals but not the cat kill Toxoplasma gondii by activating the classical complement pathway.
    Kaneko Y; Takashima Y; Xuaun X; Igarashi I; Nagasawa H; Mikami T; Otsuka H
    Parasitology; 2004 Feb; 128(Pt 2):123-9. PubMed ID: 15029999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection of murine macrophages with Toxoplasma gondii is associated with release of transforming growth factor beta and downregulation of expression of tumor necrosis factor receptors.
    Bermudez LE; Covaro G; Remington J
    Infect Immun; 1993 Oct; 61(10):4126-30. PubMed ID: 8406801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.